The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan-Reference-Cited by-同舟云学术

The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan

Published:2019-01-31 Issue:2 Volume:13 Page:157-164
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Su Shih-Yung^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/article/10.1007/s12072-019-09931-w/fulltext.html

Reference29 articles.

1. Polaris Observatory C. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol 2018;3(6):383–403. https://doi.org/10.1016/S2468-1253(18)30056-6

2. Polaris Observatory HCVC. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017;2(3):161–176. https://doi.org/10.1016/S2468-1253(16)30181-9

3. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016;388(10049):1081–1088. https://doi.org/10.1016/S0140-6736(16)30579-7

4. Chen DS. Hepatocellular carcinoma in Taiwan. Hepatol Res 2007;37(Suppl 2):S101–S105. https://doi.org/10.1111/j.1872-034X.2007.00170.x

5. Centers for Disease Control, Department of Health, Taiwan, ROC. Annual report 2012. http://www.cdc.gov.tw/uploads/files/201208/67addf76-04934d7b-aa72-cd51beff6654.pdf . Accessed 17 Feb 2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary cancer prevention for cancers with no known infectious etiology: Time for a new paradigm;Vaccine;2024-03

2. Real‐world epidemiology, treatment patterns and disease burden of patients diagnosed with chronic hepatitis B in Taiwan;Liver International;2023-08-24

3. Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study;BMC Gastroenterology;2022-08-17

4. Mortality trends in chronic liver disease and cirrhosis from 1981 to 2015 in Taiwan;Population Health Metrics;2021-10-02

5. A Survivorship-Period-Cohort Model for Cancer Survival: Application to Liver Cancer in Taiwan, 1997–2016;American Journal of Epidemiology;2021-04-20